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Acetate transfer across membranes of
artificial kidneys in vitro
KEVIN J. WINGERT and MICHAEL W. WEINER
Department of Medicine, Stanford Medical Service, Palo Alto Veterans Administration Hospital, and Stanford
University School of Medicine, Stanford, California
Acetate transfer across the membranes of artificial kidneys in
vitro. To determine the rate of acetate transfer across hemo-
dialysis membranes and to investigate the factors which influ-
ence acetate dialysance, we performed experiments with Dow-
4, Gambro-13.5, and Travenol UF-Il artificial kidneys using C-
acetate. The rate of acetate dialysance was influenced strongly
by the rate of fluid flow through the blood path, similar to the
dialysance of other low-molecular-weight solutes. The ultrafiltra-
tion of fluid from the blood path to dialysate reduced the rate of
transfer of acetate from dialysate to blood. The dialysance of
acetate was significantly less than that of urea, despite their
nearly identical molecular weights. This was not due to the direc-
tion of solute transfer. Experiments with a Kaufman-Leonard
dialyzer demonstrated that the permeability of Cuprophane
membranes to urea was greater than that to acetate was; this may
be due to the charged nature of acetate.
Transfert d'acetate a travers les membranes des reins artificiels
in vitro. Afin de determiner Ia vitesse de transfert de l'acétate a
travers les membranes d'hemodialyse, et pour étudier les fac-
teurs qui influencent la dialysance de l'acétate, des experiences
ont été réalisées avec des reins artificiels Dow 4, Gambro 13,5,
et Travenol UF-Il et du 'C acetate. La dialysance de l'acétate
est fortement influencée par le debit de liquide a travers le circuit
sanguin, de Ia méme façon que Ia dialysance d'autres solutés de
petit poids moléculaire. L'ultrafiltration de liquide du circuit
sanguin vers le dialysat réduit le transfert d'acétate du dialysat
au circuit sanguin. La dialysance de l'acétate est signifi-
cativement inférieure a celle de l'uree malgré la similitude de
leurs poids moléculaires. Cela n'est pas dO a la direction du
transfert des substances dissoutes. Les experiences avec le dia-
lyseur Kaufman-Leonard démontrent que Ia permeabilité a
l'urée des membranes de cuprophane est plus grande que celle
pour l'acdtate. Cela peut être dO a la presence de charges élec-
triques sur l'acétate.
Metabolic acidosis is a frequent complication of
acute and chronic renal failure. Hemodialysis cor-
rects acidosis by the removal of fixed acids (for ex-
ample, phosphates and sulfates) and by the addition
of bicarbonate, or a source of bicarbonate, to the
patient. During the early development of hemo-
dialysis techniques [7], bicarbonate-containing so-
lutions were used as the dialysate. This required the
cumbersome aeration of dialy sate with carbon diox-
ide to prevent precipitation of calcium salts. To sim-
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plify the hemodialysis procedure, Mion et al [8] in-
troduced the use of acetate as a source of bicarbo-
nate in dialysate solutions. Acetate is rapidly
metabolized and generates equimolar amounts of
bicarbonate [9]. Hemodialysis with acetate-contain-
ing solutions (which contain no bicarbonate), how-
ever, causes removal of large amounts of bicarbo-
nate from the blood [10]. Therefore, large amounts
of acetate must be transferred into the patient to re-
place bicarbonate losses associated with the dial-
ysis procedure, as well as to correct the acidosis
associated with renal failure. Although acetate-con-
taining dialysate solutions are used widely in clini-
cal practice, little information exists concerning the
rate of acetate transport across the membranes of
artificial kidneys [11-14]. The present study was de-
signed to quantitate acetate transfer in vitro, and to
investigate the following factors which may influ-
ence acetate dialysance: (1) type of dialyzer, (2) rate
of blood flow, (3) transmembrane pressure dif-
ference, (4) bicarbonate concentration gradient.
Methods
Materials. All studies were performed in vitro;
that is, the dialyzers were not connected to living
subjects, nor was blood used. Instead, isotonic sa-
line at 37 1° C was pumped through the blood
path and will henceforth be referred to as "blood."
A Cordis-Dow delivery system was used. The he-
modialyzers used in these experiments were: Cor-
dis-Dow model 4 hollow fiber kidney, Gambro- 13.5
parallel-plate dialyzer, and Travenol Ultraflow-Il
Coil hemodialyzer. When the Cordis-Dow or Gam-
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bro hemodialyzers were used, the "blood" and the
dialysate flowed in a counter-current direction
through the dialyzers in a single pass. The dialysate
(37 10 C) also flowed in a single pass through the
bath which contained the Travenol UF-Il. Cobe for-
mula 87 dialysate concentrate (containing, in milli-
quivalents per liter, 135 mEq of sodium, 2 mEq of
potassium, 103 mEq of chloride, 3 mEq of calcium,
1.0 mEq of magnesium, and 38 mEq of acetate) was
used. The final acetate concentration of the dialy-
sate was 38 mEq!liter. The dialysate flow was kept
constant at 500 mI/mm throughout all experiments.
Isotopes were purchased from New England Nucle-
ar, Boston, Massachusetts.
Measurement of acetate dialysance. Acetate
transfer was quantitated by the use of I ,2'4C-ace-
tate, which was added to the dialysate concentrate
at a specific activity of 29 cpm/mEq acetate.
Table I illustrates the design of all experiments.
"Blood" and dialysate flowed through each dialy-
zer for a 30-mm equilibration period before experi-
mental measurements were begun. Duplicate col-
lections of "blood" leaving the dialyzer and dialy-
sate entering and leaving the dialyzer were made for
each collection period. The rate of"blood" flow en-
tering and leaving the dialyzer and the rate of dialy-
Table 1. Experimental protocol
Collection period
"Blood" flow
mI/mm
TMPa
mm Jig
1 100 0
2 100 0
3 200 0
4 200 0
5 300 0
6 300 0
7 100 0
8 100 0
9 100 200
10 100 200
11 200 200
12 200 200
13 300 200
14 300 200
15 100 200
16 100 200
17 100 400
18 100 400
19 200 400
20 200 400
21 300 400
22 300 400
23 100 400
24 100 400
25 to 48 Entire series repeated
TMP refers to the transmembrane pressure difference be-
tween the blood path and the dialysate path.
sate flow leaving the dialyzer were measured for
each collection period with a graduated cylinder for
exactly 1 mm. The rate of ultrafiltration produced
by transmembrane pressure (TMP) gradients was
also measured with a graduated cylinder. There was
a 2-mm interval between each collection. Prelimi-
nary experiments showed that a new steady state of
"blood" and dialysate acetate concentrations was
reached within 3 mm after changing the "blood"
flow rate or transmembrane pressure. Therefore,
each time "blood" flow or transmembrane pressure
was changed, samples were collected after a 5-mm
equilibration period. The rate of flow through the
blood path was varied whereas the transmembrane
pressure was kept at 0 mm Hg (collection periods 1
to 8). The transmembrane pressure was then raised
to 200 mm Hg by producing negative pressure on
the dialysate side, and the "blood" flow was varied
again (collection periods 9 to 16). The cycle was re-
peated at a transmembrane pressure of 400 mm Hg
(collection periods 17 to 24). The entire procedure
was repeated a second time (collection periods 25 to
48). Five artificial kidneys of each type were used
for these experiments.
Comparison of urea and acetate dialysance.
These studies were performed with seven Dow-4
hollow fiber kidneys in a fashion similar to that used
to determine acetate dialysance. In these experi-
ments, 12.5 m urea, containing 14C-urea, was add-
ed to the saline which was passed through the
"blood" path. Tritiated acetate was added to the
dialysate for the measurement of acetate transfer.
The sequence of measurements shown in Table I
(collection periods 1 to 24) was performed once for
each artificial kidney studied at a transmembrane
pressure of zero.
Effect of bicarbonate on acetate dialysance. Ex-
periments designed to investigate the effect of bi-
carbonate on acetate dialysance were performed
with six Dow-4 hemodialyzers. The protocol depict-
ed in Table 1 (periods 1 to 24) was followed at a
transmembrane pressure of zero. Initially, 140 mM
sodium chloride was used on the "blood" side. Af-
ter the rate of acetate dialysance was measured (pe-
riods 1 to 24), a solution containing 126 m sodium
chloride and 14 m sodium bicarbonate was passed
through the "blood" compartment, and the identi-
cal sequence of measurements was repeated.
Acetate permeability of Cuprophane membranes.
The rate of acetate transfer across NIH reference
Cuprophane was measured by Dr. Elias Klein and
F. Holland at the Gulf South Research Institute in
New Orleans, Louisiana, using a Kaufman-Leonard
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K0= in
A(1
-
QD
(5)
where A is membrane surface area (cm2).
The mass transfer coefficient for the "well-
mixed" dialysate of the Travenol UF-Il coil was
calculated by the formula [17]:
stirred-bath dialyzer [15]. Acetate (1,214C) was dis-
solved in 150 m sodium chloride, and the experi-
ments were performed at 37° C [16].
Analytic techniques. Radioactivity was deter-
mined by adding 0.5-mi aliquots of "blood" and
dialysate solutions to 10 ml of Aquasol. The radio-
activity was determined with a Nuclear Chicago
Liquid Scintillation Counter. When '4C and 3H were
used together, a dual-label program was used.
Calculations. Although the term "dialysance" is
customarily used to indicate the transfer of solute
from "blood" to dialysate, in this report dialysance
will refer to the transfer of acetate from dialysate to (1 + —
the "blood" path. Dialysance was calculated with K = — -ln I Q QD, (6)
generally accepted equations [17]. Because solute A fP — 1
was added to the "blood" side, the inflow and out- L QB) QD
flow terms of the conventional equations [17] were
reversed to avoid negative numbers.
,., \ / All data shown are expressed as the mean SEM.
DialysanceB = — QiC81, (1) Significance between means was calculated using(CD1 — CBI) Student's t test.
DialysanceD = (QDICDi)
— (QDOCDO) (2) Results
Acetate transfer by the Gambro-13.5 herno-
CB! acetate was always 0 because the blood did dialyzer (Fig. 1). Figure 1 depicts the dialysance of
not recirculate (that is, blood flowed in a single-pass acetate by the Gambro-.13.5 parallel-flow dialyzer.
fashion). Therefore: The dialysance, expressed in milliliters per minute,
QBOCBO is plotted as a function of the rate of fluid flowDialysance =
CD!
(3) through the "blood" path. The three lines represent
transmembrane pressure differences of 0, 200, and
Dialysance = (QD!CD1)
— (QDOCDO) (4) 400mm Hg. The data show that the rate of "blood"
CD1 flow strongly influences the rate of acetate transfer
where C is concentration, in microequivalents per from the dialysate into the blood compartment. This
milliliter; Q is flow, in milliliters per minute; B is curvilinear relationship is similar to that reported
"blood"; D is dialysate; Bi is "blood" flowing into for the dialysance of other small solutes from
the dialyzer; Bo is "blood" flowing out of the dialy- "blood" to dialysate [10]. This figure also illustrates
zer; Di is dialysate flowing into the dialyzer; and Do the effect of transmembrane pressure differences.
is dialysate flowing out of the dialyzer. To prevent Raising the transmembrane pressure to 200 mm Hg
calculation errors, dialysance was calculated with had no significant effect on acetate dialysance by
both "blood flow" rate (equation 3) and the dialy- the Gambro-13.5 hemodialyzer. When the trans-
sate flow rate (equation 4). The values for dialy- membrane pressure difference was increased to 400
sance were always within 10% of each other, and mm Hg, however, the transfer of acetate from dialy-
there was no consistent variation in one direction; sate to "blood" was significantly depressed (P <
therefore, a mass balance of acetate could be ac- 0.01).
counted for. When ultrafiltration was induced by Acetate transport by the Dow-4 hollow fiber kid-
transmembrane pressure, the flows of "blood" and ney (Fig. 2). The dialysance of acetate by the Dow-4
dialysate changed, and the appropriate values were hollow fiber kidney is depicted in Fig. 2. Acetate
used. dialysance has been plotted as a function of the rate
The mass transfer coefficient (K0) of dialyzers in- of "blood" flow. The results of transmembrane
dicates the capacity for solute transfer. The mass pressures of 0, 200, and 400 mm Hg are shown.
transfer coefficients for the Dow-4 and Gambro-13.5 Similar to the Gambro 13.5, the rate of acetate
hemodialyzers were calculated by the formula [17] transfer by the Dow 4 was markedly influenced by
for countercurrent flow: the "blood" flow rate. A transmembrane pressure
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"Blood' flow,mI/min
Fig. 1. Effects of "blood ' flow on acetate dialysance by the
Gambro 13.5. The closed circles and solid line (•—S) represent
TMP = 0 mm Hg. The closed squares and dotted line (U U)
represent TMP = 200 mm Hg. The closed triangles and dashed
line (A---A) represent TMP = 400 mm Hg. The SEM is smaller
than the symbols. An asterisk at a "blood" flow of 100 mI/mm
indicates that this value is significantly different (P <0.05) from
the value at 200 mI/mm, at the same transmembrane pressure.
An asterisk at a "blood" flow of 200 mi/mm indicates that the
value is significantly different (P <0.05) from the value at 300 ml!
mm, at the same transmembrane pressure. An asterisk at a
"blood" flow of 300 mI/mm indicates that the value is significant-
ly different (P <0.05) from the value at 100 mI/mm at the same
transmembrane pressure. The dialysance values at a TMP of 400
mm Hg are significantly lower (P <0.01) than the values at 0 and
200 mm Hg are.
gradient of 200 mm Hg did not significantly affect
acetate dialysance, but a transmembrane pressure
of 400 mm Hg significantly reduced acetate transfer
at all rates of "blood" flow.
Acetate transport by the Travenol UF-JI stan-
dard coil kidney (Fig. 3). The dialysance of acetate
by the UF-Il coil is shown in Fig. 3. Acetate dialy-
sance has been plotted as a function of the "blood"
flow rate at transmembrane pressure of 0, 150, and
300 mm Hg. Similar to the Dow 4 and Gambro 13.5,
the rate of acetate transfer was markedly influenced
by "blood" flow rate. Raising the transmembrane
pressure to 150 mm Hg (at a "blood" flow rate of
300 mI/mm) caused a significant (P < 0.01) decrease
in dialysance, and a further increase of trans-
membrane pressure to 300 mm Hg diminished ace-
tate dialysance to a greater extent.
Comparison of the mass transfer coefficient of
acetate for the Dow-4 Gambro-13.5 and Travenol
UF-Il hemodialyzers (Table 2). When the mass
transfer coefficients for acetate of the three types of
"Blood" flow, rn//mm
Fig. 2. Effects of "blood" flow on acetate dialysance by the
Dow-4 hollow fiber kidney. The closed circles and solid line (•—
•) represent TMP = 0 mm Hg. The closed squares and dotted
line (U . U) represent TMP = 200 mm Hg. The closed triangle
and dashed line (A---A) represent TMP = 400 mm Hg. The SEM
is smaller than the symbols. An asterisk at a "blood" flow of 100
mi/mm indicates that this value is significantly different (P <
0.05) from the value at 200 mI/mm, at the same transmembrane
pressure. An asterisk at a "blood" flow of 200 mI/mm indicates
that the value is significantly different (P <0.05) from the value
at 300 mI/mm, at the same transmembrane pressure. An asterisk
at a "blood"flow of 300 mi/mm indicates that the value is signifi-
cantly different (P < 0.05) from the value at 100 mI/mm at the
same transmembrane pressure. The dialysance value at a TMP of
400 mm Hg is significantly (P <0.01) greater than the values at 0
and 200 mm Hg are at all rates of blood flow.
hemodialyzers were compared, the value for the
Gambro was found to be significantly greater than
that for the Dow was, and the UF-Il coil had the
highest value. This is in contrast to previous studies
which have suggested that other solutes are dia-
lyzed more rapidly by the Dow-4 than they are by
the Gambro-13.5 or by coil hemodialyzers [18].
Comparison of urea and acetate dialysance in the
Dow-4 hemodialyzer (Table 3). Although urea and
acetate have the same molecular weight, the rates
of acetate transfer measured in this investigation
are lower than those reported for urea. For this rea-
son, the dialysances of urea from "blood" to dialy-
sate and acetate from dialysate to "blood" were di-
rectly compared by dual isotope counting. Table 3
indicates that at all "blood" flows and at all trans-
membrane pressures, the rate of urea transfer was
significantly higher than the rate of acetate transfer
was.
Effects of direction of solute transfer on acetate
dialysances. In the experiments comparing urea
150-
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and acetate dialysances, the two solutes were stud-
ied while being transferred in opposite directions.
To determine if the direction of transfer influenced
acetate transfer, we compared the rate of acetate
dialysance from "blood" to dialysate directly with
acetate dialysance from dialysate to "blood" at ze-
ro transmembrane pressure. The results with three
Dow-4 hemodialyzers indicate that the direction of
transfer had no effect on the rate of acetate dialy-
sance.
Comparison of acetate and urea transfer across
isolated Cuprophane membranes (Table 4). To in-
vestigate whether the difference between the dialy-
sance of acetate and urea was due to differences in
the transfer across the dialysis membrane, we per-
formed experiments with a Kaufman-Leonard
stirred-bath dialyzer. Table 4 demonstrates that the
permeability of the cuprophane membrane to ace-
tate is 54% of the permeability to urea.
Effects of bicarbonate on acetate dialysance by
the Dow-4 hemodialyzer (Table 5). A major function
E
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"Blood" flow, rn//rn/n
Fig. 3. Effects of 'blood" flow on acetate dialysance by the
Travenol UF-JI. The closed circles and solid line (•—S) repre-
sent TMP = 0 mm Hg. The closed square and dotted line
(U' U) represent TMP = 200 mm Hg. The closed triangles and
dashed line (A---A) represent TMP = 300 mm Hg. The SEM is
smaller than the symbols. An asterisk at a "blood" flow of 100
mi/mm indicates that this value is significantly different (P < 0.05)
from the value at 300 mI/mm, at the same transmembrane pres-
sure. An asterisk at a "blood" flow of 200 mI/mm indicates that
the value is significantly different (P <0.05) from the value at 300
mi/mm, at the same transmembrane pressure. An asterisk at a
"blood" flow of 300 mI/mm indicates that the value is significant-
ly different (P <0.05) from the value at 100 mllmin at the same
transmembrane pressure. At TMP = 150 mm Hg, DAe is signifi-
cantly less than it is at TMP = 0 mm Hg. At TMP = 300 mm Hg,
DA, is significantly less than it is at TMP = 150 mm Hg.
Table 2. Mass transfer coefficienta
K0, cm/mm
Gambro 13.5(N = 5)
Dow4,(N = 5)
0.0155
0.0144
0.0003
0.0003
UF II, (N = 5) 0.0167 0.0004
a Data for all blood flows are combined. Transmembrane pres-
sure gradient = 0. The value for each type of artificial kidney is
significantly (P < 0.01) different from the others.
of acetate in hemodialysis is to replace the bicarbo-
nate loss during dialysis treatment. Furthermore,
the rate of transfer of acetate (from dialysate to
blood) might be expected to be influenced by the
countermovement of other anions, especially bi-
carbonate, or chloride, or both (from blood to dialy-
sate). To investigate this possibility, we studied the
effects of bicarbonate in the "blood" on acetate
dialysance.
Table 5 indicates that the presence of bicarbonate
in the "blood" had no significant effect on dialy-
sance of acetate at various flows and trans-
membrane pressures. Therefore, the presence of bi-
carbonate in the "blood" appears to have no influ-
ence on the rate of acetate transfer from dialy sate to
"blood."
Calculated rates of acetate transfer (Table 6). To
indicate the clinical significance of the magnitude of
acetate dialysance, we calculated from the present
data the rates of acetate transfer by the three types
of hemodialyzers investigated; the results are ex-
pressed in milliequivalents per hour.
Discussion
The results of the present in vitro experiments
demonstrate that the transfer of acetate by hemo-
dialyzers is influenced by the rate of flow through
the "blood" path and by the rate of ultrafiltration.
These findings are generally similar to those ob-
tained with other relatively low-molecular-weight
solutes [10], but there are several differences be-
tween the present data with acetate and previous
results.
The presence of a transmembrane gradient (great-
er on the "blood" side) diminished acetate dialy-
sance from dialysate to "blood" by all dialyzers
studied. Previous investigations concerning the ef-
fects of ultrafiltration on solute transfer from blood
to dialysate have suggested that several factors may
have contributed to this change, including a de-
crease in effective membrane surface area [19, 20]
or alteration of the geometry of the blood or dialy-
sate path [19, 21]. Additionally, in the present in-
vestigations, the convective transfer of fluid was in
0 300
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Table 3. Comparison of urea and acetate in the Dow—4 hollow-fiber kidneya
TMP
mm Hg
QB
mi/mm
DialysanceB, mi/mm
Acetate
38mEqiliter
Urea
12.5 mM
0
0
0
200
200
200
400
400
400
101
200
298
97
193
293
90
195
290
86 1
122±5
139 4
79 I
118 3
137 4
69 I
111±2
129 3
P < 0.001
P<O.01
P < 0.001
P < 0.01
P < 0.001
P < 0.001
P < 0.02
P<0.001
P < 0.001
95 I
151±5
181 4
96 I
154 2
190 4
96 2
160±2
186 3
a Abbreviations are defined as TMP, transmembrane pressure gradient; QB, flow rate through the blood path. Flow rate (QD) through
the dialysate path was 500 mI/mm. Number of kidneys was 7. Values are mean SEM.
the direction opposite to the direction of solute
transfer. Thus, there are at least two other possible
explanations for the present results: first, some of
the acetate diffusing into the "blood" path may
have been carried back to the dialysate by con-
vective flow. Second, the bulk flow of "blood"
across the membrane would be expected to dimin-
ish the acetate concentration on the dialysate sur-
face, similar to the mechanism proposed by Husted
et al [22]. This effect would diminish the acetate gra-
dient and thus would reduce diffusive transfer. Al-
though each of the above factors may contribute to
the effect of ultrafiltration on acetate dialysances,
their relative importance is not known.
The effect of transmembrane pressure on acetate
dialysance has clinical significance because ultrafil-
tration increases the rate of bicarbonate removal
from the "blood." Therefore, during hemodialysis
in vivo, ultrafiltration would be expected to in-
crease bicarbonate losses, while reducing acetate
transfer into the patient. Both factors would slow
the correction of metabolic acidosis and might con-
tribute to the hypotension produced by ultrafiltra-
tion.
Table 2 demonstrates that the mass transfer coef-
ficient for acetate is lowest for the Dow-4 hollow
fiber kidney and highest for the Travenol UF-JI coil.
In contrast, the mass transfer coefficient for urea is
highest for the Dow-4 hollow fiber kidney [18]. Al-
though the membrane and dialysate resistances af-
fect urea diffusion, the thickness of the blood film is
generally thought to be rate limiting for urea trans-
fer by hemodialyzers. Because the Dow 4 has the
thickest membrane (30 compared with 13.5 p for
the Gambro and Travenol), the data in Table 2 sug-
gest that the rate of acetate transfer through the
membrane, and not the thickness of the blood film,
may be rate limiting.
The difference between the transport of acetate
and urea across hemodialysis membranes is empha-
sized by the results in Tables 3 and 4. Although urea
and acetate have a molecular weight of about 60 dal-
tons, the dialysance of urea by the Dow 4 is signifi-
cantly greater than the dialysance of acetate is. The
present experiments showed that this was not due
to the direction of transfer, because the direction of
solute movement had no effect on the rate of acetate
dialysance. The findings (Table 4) that the Cupro-
phane membranes are less permeable to acetate
than they are to urea provide an explanation for the
dialysance results. This difference between acetate
and urea is probably related to differences in hy-
drated radii. The hydrated radius of acetate has
been reported to be 5.2 A) [23] and the hydrated
radius of urea has been reported to be 2.3 A [24],
but these estimates were made using different tech-
niques and may not be directly comparable. Per-
haps the charged nature of the acetate ion, or its
molecular structure, results in a particle with a
greater hydrated radius than urea has. In addition,
charges fixed to the dialysis membranes may retard
transfer of ions. The dialysances of acetate and bi-
carbonate were not directly compared in the pres-
ent experiments. The dialysance of acetate, how-
ever, appears to be considerably less than that of
bicarbonate [14] (hydrated radius estimated to be
4.72 A [23]), despite their similar negative charge
and molecular weight. This further suggests that
Table 4. Permeability of Cuprophan to acetate and urea
Membrane
permeability
cm/sec
Diffusion
coefficient
cm2' sec
Acetate 5.4 x 10 1.3 x l0
Urea 10.0 x 10 1.8 >< l0
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TableS. Effects of bicarbonate on acetate dialysance in the Dow 4
Composition of "blood" dialysance
Transmembrane
pressure QB
mi/mm
NaC1 NaCI (126 mEq/liter)
mm Hg mi/mm 140 mEq/liter P NaHCO3 (14 mEq/liter)
0 102 83±1 NS 80±4
0 299 147 2 NS 147 4
400 92 69±3 NS 70±2
400 286 136 3 NS 135 3
a N = 6 for each value; Q1 = 500 mI/mm.
molecular shape or hydrated radius may be a pri-
mary determinant of solute transfer across dialysis
membranes.
To maintain electrical neutrality, the dialysis
membrane's acetate transfer must be accompanied
by concurrent transfer of a cation or countercurrent
transfer of an anion. Because the role of acetate in
dialysate solutions is to replenish bicarbonate, we
investigated the effect of bicarbonate in the
"blood" path on acetate dialysance. The presence
or absence of bicarbonate in the "blood" had no
influence on the rate of acetate transfer. The clinical
significance of this finding is that the rate of acetate
influx into the patient appears to be independent of
the extent of metabolic acidosis.
To estimate the rate of acetate transfer during he-
modialysis, we calculated the data in Table 5. It
should be emphasized that these values are based
on in vitro measurement with saline in the "blood"
path. The rising concentrations of acetate in arterial
blood during dialysis of patients [11-14] would re-
duce the concentration gradient for acetate between
the dialysate and the blood and diminish the net
transfer. In vivo investigations will be required to
determine the rate of acetate transfer during hemo-
dialysis of uremic subjects and to determine the fac-
tors which influence acetate dialysance.
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